Misra Ikhita, Rath Bandana, Rath Ishani, Mondal Himel
Otorhinolaryngology, Shri Jagannath Medical College and Hospital, Puri, IND.
Pharmacology, Saheed Laxman Nayak Medical College and Hospital, Koraput, IND.
Cureus. 2024 Apr 24;16(4):e58949. doi: 10.7759/cureus.58949. eCollection 2024 Apr.
Background Facial nerve paralysis, leading to the loss of facial expression, poses significant discomfort to patients. While most individuals exhibit a favorable response to treatment, a subset experiences enduring facial deformities without clearly defined etiology. This study aimed to identify prognostic factors influencing outcomes and quality of life in facial nerve palsy patients, contributing to enhanced clinical management. Methods A prospective observational study was conducted in the Otorhinolaryngology Department of Maharaja Krishna Chandra Gajapati Medical College and Hospital, a tertiary care hospital. We included patients presenting with any clinical variety of facial nerve palsy, irrespective of age and gender. Only moribund and noncompliant cases were excluded. Patients underwent clinical assessment using the House-Brackmann (HB) grading at presentation and were subsequently monitored at three weeks, three months, and six months post-onset to assess recovery. Results Out of 66 patients, 18 (27.27%) fully recovered at three weeks, 50 (75.76%) recovered at three months, and 54 (81.82%) at six-month follow-up. Incomplete recovery was observed in 13 (19.69%) patients. Factors associated with favorable outcomes included younger age of onset (p = 0.003), lower baseline HB grade (IV or less) (p = 0.001), Electroneurography Degeneration Index (ENoG DI) of <70% (p < 0.0001), early initiation of treatment (within five days of onset) (p = 0.0003), and absence of comorbid conditions (p = 0.03). Gender and affected side (left or right) did not influence the outcome. Conclusion In summary, age, associated comorbid conditions, baseline HB grade, and extent of facial nerve degeneration are crucial predictors of outcomes in facial nerve palsy. This knowledge can guide clinicians in optimizing treatment strategies for improved patient care.
背景 面神经麻痹会导致面部表情丧失,给患者带来极大不适。虽然大多数患者对治疗反应良好,但仍有一部分患者会出现持续性面部畸形,且病因尚不明确。本研究旨在确定影响面神经麻痹患者预后和生活质量的预后因素,以改善临床管理。方法 在一家三级护理医院——马哈拉贾·克里希纳·钱德拉·加贾帕蒂医学院和医院的耳鼻喉科进行了一项前瞻性观察研究。我们纳入了患有任何临床类型面神经麻痹的患者,不分年龄和性别。仅排除濒死和不配合的病例。患者在就诊时使用House-Brackmann(HB)分级进行临床评估,随后在发病后三周、三个月和六个月进行监测以评估恢复情况。结果 66例患者中,18例(27.27%)在三周时完全恢复,50例(75.76%)在三个月时恢复,54例(81.82%)在六个月随访时恢复。13例(19.69%)患者恢复不完全。与良好预后相关的因素包括发病年龄较小(p = 0.003)、基线HB分级较低(IV级或更低)(p = 0.001)、神经电图变性指数(ENoG DI)<70%(p < 0.0001)、早期开始治疗(发病后五天内)(p = 0.0003)以及无合并症(p = 0.03)。性别和患侧(左侧或右侧)不影响预后。结论 总之,年龄、合并症、基线HB分级以及面神经变性程度是面神经麻痹预后的关键预测因素。这些知识可指导临床医生优化治疗策略,以改善患者护理。